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Abstract 
We describe two Finnish siblings in whom an incidentally detected elevated creatine kinase activity eventually led to a diagnosis of 
limb-girdle muscular dystrophy-dystroglycanopathy (Type C12; MDDGC12). When diagnosed at age 10 and 13 years, they were mildly 
affected with a slow or non-progressive disease course. The main symptoms comprised infrequent hip cramps triggered by flexion, neck 
cramps triggered by yawning, transient growing pains, calf hypertrophy and mild proximal muscle weakness. Their cognitive and motor 
developments were unremarkable and they were physically active. Whole-exome sequencing revealed compound heterozygous mutations, both 
of which were novel, in the protein O-mannosyl kinase (POMK) gene in both siblings; a missense mutation, p.Pro322Leu (c.965C > T), 
and a nonsense mutation, p.Arg46Ter (c.136C > T). The results were confirmed by Sanger sequencing, showing that the parents were 
heterozygous carriers of one mutation each. This report adds to the literature by providing phenotype and genotype data on this ultra-rare 
POMK -related dystroglycanopathy. 
© 2018 Elsevier B.V. All rights reserved. 
Keywords: Protein-O-mannosyl kinase; POMK ; Dystroglycanopathy; Limb-girdle muscular dystrophy-dystroglycanopathy type 12 C; MDDGC12; 
LGMD12C; Muscular dystrophy. 
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0. Introduction 
Dystroglycanopathies are a group of muscular dystrophies
haracterised by considerable clinical and genetic heterogene-
ty. They are caused by disruption in the interactions between
he transmembrane protein dystroglycan and extracellular ma-
rix components. These interactions are necessary for normal∗ Corresponding author at: The Folkhaelsan Department of Medical Genet- 
cs, Topeliusgatan 20, 00250 Helsinki, Finland. 
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https://doi.org/10.1016/j.nmd.2018.04.012 uscle and brain development [1] . In these interactions, gly-
osylation plays a crucial role. Most known dystroglycanopa-
hy mutations are located in genes related to the glycosylation
rocess rather than in the dystroglycan gene itself [1] . 
The POMK gene (MIM 615247), located on chromosome
p11, encodes the protein O-mannose kinase which is nec-
ssary for proper glycosylation and function of the dystro-
lycan complex [2] . Biallelic mutations in the POMK gene
ause limb-girdle muscular dystrophy-dystroglycanopathy 
type C12; MDDGC12) (MIM 616094). To our knowledge,
wo such families have been described; one in which twoovel compound heterozygous mutation in the P OMK 
athy in a sib pair, Neuromuscular Disorders (2018), 
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pJordanian sibs presented with limb-girdle muscular dystro-
phy (LGMD) and cognitive impairment, and another in
which a child born to consanguineous parents presented
with LGMD, mild learning difficulties and congenital mir-
ror movements [1,3] . POMK mutations can also cause the
more severe Walker–Warburg syndrome (Muscular dystrophy-
dystroglycanopathy, congenital with brain and eye anomalies,
type A12; MDDGA12) (MIM 615249), encompassing brain
and eye abnormalities in addition to the muscular dystrophy.
To our knowledge, three such families have been described in
previous reports [1,2,4] . Due to the small number of cases de-
scribed, little is known about the range of clinical variability
of disorders caused by POMK mutations. 
We report clinical, molecular, histological, neurophysiolog-
ical and imaging data on a sib pair with limb-girdle muscular
dystrophy-dystroglycanopathy type C12, caused by a novel
compound heterozygous mutation in the POMK gene. The
incidental finding of an elevated serum creatine kinase (CK)
activity in the probands in infancy, which eventually led to
the diagnosis, allowed for observation of the onset and the
progression of the disease. 
2. Case report 
2.1. Clinical phenotype 
The probands comprise a Finnish sib pair born to non-
consanguineous parents. The older sister was born at term
with birth asphyxia due to placental abruption. She suffered
a mild asphyxia-related kidney injury for which she was on
follow-up. At 6 years of age, while being investigated for el-
evated liver enzymes, she presented with elevated CK values
of 1000–4000 U/L. Her motor and cognitive developments as
well as her growth were normal. She started walking at age
15 months. Her visual acuity was normal. She had unilateral
high-frequency hearing loss (hearing threshold 65 decibel at
6000 and 8000 Hz). In childhood she suffered from transient
growing pains. Since school age she has experienced infre-
quent hip cramps triggered by hip flexion when doing for
instance sit-ups, and by cramps in the neck region triggered
by yawning. She has, at times, suffered from exercise-induced
knee ache. Testing of muscle strength at 10 years of age us-
ing myometry showed muscle power slightly below average
for hip adductors and abductors, as well as for knee exten-
sors and ankle plantar flexors, as compared with normative
values. On the contrary, muscle power in other arm and leg
muscle groups were equal to or even stronger than average
[5] . Subsequent evaluations showed muscle strength within
normal limits. 
Her electromyography (EMG) findings were normal, how-
ever, only one muscle (right gastrocnemius) was examined
due to her fear of needles. Neurography of the median, tib-
ial peroneal and sural nerves gave normal results. A muscle
biopsy at 7 years of age was paraffin-embedded and showed
normal findings. Echocardiography (followed up every two
years starting from 7 years of age, with the latest evaluation
done at 14 years of age) and spirometry showed no signs ofPlease cite this article as: S. Strang-Karlsson et al., A n
gene causing limb-girdle muscular dystrophy-dystroglycanop
https://doi.org/10.1016/j.nmd.2018.04.012 ardiac or respiratory involvement. Magnetic resonance imag-
ng (MRI; 1,5 T scanner) with T1-weighted and STIR images
f muscles in shoulders, upper arms, thighs and pelvic region
as normal, without signs of fatty replacement or edema (not
hown). 
The younger brother was born preterm by caesarean sec-
ion due to placenta praevia. His motor and cognitive devel-
pments as well as his growth were unremarkable. He started
alking at age 13 months. He had normal hearing and vi-
ual acuity. As a consequence of his sisters´ incidentally de-
ected CK elevation, his CK level was determined, showing
arkedly increased levels of up to 6800 U/L. In childhood,
e suffered from transient nocturnal growing pains. He also
uffered from thigh stiffness and infrequent pain and cramps
n the thighs and groins triggered by hip flexion. Like his sis-
er, he experienced infrequent neck region cramps triggered
y yawning. Muscle strength in his hip abductors and adduc-
ors as well as upper limbs was slightly weak, making it, at
imes, difficult for him to do sit-ups and arm push-ups. 
His EMG was normal (neurography of tibial, peroneal and
ural nerve, as well as myography of vastus lateralis, tibialis
nterior and biceps). A muscle biopsy taken from the vastus
ateralis muscle at age 6 showed moderate chronic myopathic
hanges, small groups of regenerating fibres, sparse inflam-
atory cell infiltrates, α-dystroglycan deficiency in a major-
ty of fibres with preserved expression in single, scattered
bres and normal merosin immunolabelling ( Fig. 1 ). The ma-
or histocompatibility complex 1 (MHC1) protein was slightly
p-regulated (not shown). Electrocardiography (ECG) showed
solated persistent deep Q-waves in leads V5-6 from the age
f 5 years onwards. At the age of 7 years, the boy had a his-
ory of syncope of unknown etiology (electroencephalography,
chocardiography and 24-h ECG were normal). Echocardio-
raphy was normal at initial evaluation at the age of 5 years
ut gradually turned pathological after the age of 8 years, re-
ealing mild enlargement and borderline weakened function
f the left ventricle by the age of 12 years. No cardiac MRI
as done. The boy is on regular cardiac follow-up (echocar-
iography and 24-h ECG) every 6–24 months and receives
o treatment. There were no signs of respiratory involvement.
RI findings (1,5 T, T1-weighted and STIR images) in the
uscles of the shoulder region, upper arms, thighs and pelvic
egion were within normal limits, without signs of fatty re-
lacement, although with minimal high signal changes in the
ight shoulder and left pelvic and thigh regions (not shown). 
On clinical examination at age 13 and 10 years, re-
pectively, both the sister and brother had calf hypertrophy
 Fig. 2 ), mild lumbar lordosis and slightly winged scapulae,
risk tendon reflexes (interpreted as normal) in the lower ex-
remities, weakened but positive tendon reflexes in the up-
er extremities, absent Babinski signs and negative Gow-
rss´igns. They had no mirror movements, which have been
elated to POMK mutations in a previous report [3] . The
rother had difficulty in walking on heels. Both sibs were
hysically active and considered themselves symptom-free
nd as physically fit as their peers. Brain MRI was not
erformed. ovel compound heterozygous mutation in the P OMK 
athy in a sib pair, Neuromuscular Disorders (2018), 
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Fig. 1. Muscle biopsy of the brother demonstrating (a) small groups of regenerating fibres (Hematoxylin eosin, ×200), (b) sparse inflammatory cell infil- 
trates (Hematoxylin eosin, ×400), (c) weak alpha-dystroglycan expression with preserved staining in scattered single fibres (immunohistochemistry, alpha- 
dystroglycan, ×400), (insert shows alpha-dystroglycan expression in a control muscle biopsy), and (d) normal merosin immunolabeling (immunohistochemistry, 
merosin, ×400). 
Fig. 2. Photographs of the probands showing calf hypertrophy, slightly accentuated lumbar lordosis and slightly winged scapulae. 
Please cite this article as: S. Strang-Karlsson et al., A novel compound heterozygous mutation in the P OMK 
gene causing limb-girdle muscular dystrophy-dystroglycanopathy in a sib pair, Neuromuscular Disorders (2018), 
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rFamily history of muscle disease was non-contributory, and
the parents´CK levels were normal. 
2.3. Molecular findings 
The patients were enrolled into the MYO-SEQ project
(myo-seq.org), an international research collaboration that
applies whole exome sequencing (WES) to patients with un-
diagnosed limb-girdle muscle weakness. At least 250 ng of
DNA ( > 2 ng/ μl) for each sibling was used as a template
for WES. The resulting data were processed by the Ge-
nomics Platform at the Broad Institute of Harvard and MIT
(Boston, MA, USA) as described previously [6] . The variant
call set was uploaded onto the Broad Institute of Harvard and
MIT’s seqr platform ( https://www.seqr.broadinstitute.org ) and
POMK was analysed for biologically relevant variants previ-
ously described by Johnson et al. [7] . 
Both siblings were shown to harbour two rare vari-
ants in POMK . The first was a stop-gained nonsense mu-
tation, p.Arg46Ter (hg19 chr8:42958827, c.136C > T),
and the second was a missense mutation, p.Pro322Leu
(hg19 chr8:42977932, c.965C > T). Both variants are
very rare in the control population (minor allele frequency
[MAF] < 0.0001) and have never been found in homozygo-
sis. Sanger sequencing confirmed the presence of the variants
in trans in the siblings. Each unaffected parent was only het-
erozygous for one of the variants each. We have submitted
the variants and phenotype descriptions to a public database;
the Leiden Open Variant Database ( https://www.LOVD.nl). 
3. Discussion 
The POMK gene (synonym SGK196) encodes a 350 amino
acid protein comprising 5 exons [4] . The full-length wild-
type POMK protein has a predicted molecular weight of
40.15 kDa. The gene is conserved in mammals and amphib-
ians [2] . Supporting the presumption that POMK mutations
cause muscle disease, Di Costanzo and colleagues observed
high expression of POMK in muscle and brain tissues during
fetal development, especially during myocyte differentiation.
In zebrafish embryos, knockdown of POMK led to muscular
dystrophy, stressing the importance of POMK for early mus-
cle development [1] . Moreover, protein analysis studies by
von Renesse et al. showed an absence of POMK protein ex-
pression in fibroblasts and muscle cells derived from patients
with homozygous truncating POMK mutations, whereas such
expression was present in controls [2] . 
The novel mutations in our patients comprised one non-
sense mutation (p.Arg46Ter) in exon 4, resulting in a pre-
mature termination of the amino acid sequence, and a mis-
sense mutation (p.Pro322Leu) in exon 5. High Combined
Annotation-Dependent Depletion (CADD) scores of 35 and
27.7, respectively, suggest both variants are damaging to the
protein [8] . Interestingly, all cases with POMK -related dys-
troglycanopathies reported to date have at least one mutation
in exon 5 [1–4] . Despite the lack of functional studies of the
specific mutations identified in our patients, the phenotype,Please cite this article as: S. Strang-Karlsson et al., A n
gene causing limb-girdle muscular dystrophy-dystroglycanop
https://doi.org/10.1016/j.nmd.2018.04.012 onsistent with LGMD, the elevated CK activity as well as
he α-dystroglycan deficiency in the muscle biopsy of the
rother strongly argues for pathogenicity of the mutations.
e interpret the slight up-regulation of MHC 1 as unspecific
nd compatible with the occurrence of occasional inflamma-
ory infiltrates sometimes seen in muscle biopsies of patients
ith muscular dystrophy. Hence, the current report supports
revious studies claiming a causative role of POMK mutations
n dystroglycanopathies. 
POMK -related dystroglycanopathies are ultra-rare autoso-
al recessive disorders. To our knowledge, when taking into
ccount the current study, there are, to date, nine published
ases from six different families [1–4] . As with dystrogly-
anopathies in general, their phenotypic presentations vary
idely. On comparison with the published cases, we were
nable to pinpoint any clear-cut genotype-phenotype correla-
ion. Whether this lack of correlation is explained by chance
ue to the small sample, or by a factual lack of correlation,
emains to be seen as new cases are identified in the future.
ur two patients, who had a childhood onset of mild LGMD
ith normal cognition, represent the least severe phenotype
mong the published POMK cases. The mild cardiac involve-
ent observed in the boy, however, has not been reported
reviously and may either represent a new phenotypic feature
f POMK -related dystroglycanopathies or be unrelated to it.
he two Jordanian sibs with MDDGC12 had a clinical pre-
entation of infancy-onset, fairly slowly progressive LGMD
ith cognitive deficit, caused by a severe protein-truncating
omozygous missense mutation in POMK [1] . Interestingly,
he same allelic variant was identified in a more severely af-
ected Lebanese sib pair diagnosed with MDDGA12, who had
nfancy-onset muscle weakness and hypotonia, developmen-
al delay, wheel-chair dependency, affected vision and brain
RI abnormalities – again illustrating the wide phenotypic
ariation [2] . Furthermore, the adolescent boy reported by
rdicli et al. had childhood-onset slowly progressive LGMD
ith congenital mirror movements and brain abnormalities
n MRI, caused by a homozygous missense mutation in
OMK [3] . Finally, an Italian boy diagnosed with MDDGA12
ad a severe infancy-onset phenotype of hypotonia, cognitive
mpairment, epilepsy, and brain and eye abnormalities. He
eceased at the age of 4 years and had a compound het-
rozygous POMK mutation; one frameshift mutation caus-
ng a premature termination and another mutation caus-
ng the substitution of a highly conserved amino acid in
xon 5 [1] . 
In summary, we report novel compound heterozygous
OMK mutations in two siblings with a childhood on-
et LGMD, who are mildly affected with a slow or non-
rogressive disease course. They were cognitively unaffected
nd seemed to have isolated muscle affection, however, the
ardiac pathology in the brother may constitute a new pheno-
ypic feature of MDDGA12C. This report adds to the litera-
ure by providing new phenotypic data on this ultra-rare dis-
ase. As with rare diseases in general, further case reports are
eeded to elucidate the entire phenotypic spectrum of POMK -
elated dystroglycanopathies. ovel compound heterozygous mutation in the P OMK 
athy in a sib pair, Neuromuscular Disorders (2018), 
S. Strang-Karlsson et al. / Neuromuscular Disorders 000 (2018) 1–5 5 
ARTICLE IN PRESS 
JID: NMD [m5+; June 13, 2018;19:12 ] 
A
 
t  
s  
t  
s  
s  
f  
d  
d  
C  
c  
q  
r
R
[  
 
 
[  
 
 
[  
 
 
[  
 
 
[  
 
[  
 
 
[  
 
 
[  
 cknowledgements 
We are grateful to the family who gave their permission
o publish data and photographies. This study was financially
upported by the Sigrid Jusélius Foundation, the Associa-
ion Francaise contre les Myopathies, the Finska Läkaresäll-
kapet, Muscular Dystrophy UK and the Medicinska under-
tödsföreningen Liv och Hälsa. The MYO-SEQ study was
unded by Sanofi Genzyme, Ultragenyx, Kurt + Peter Foun-
ation, LGMD2I Research Fund, Samantha J Brazzo Foun-
ation, LGMD2D Foundation, Muscular Dystrophy UK and
oalition to Cure Calpain 3. The companies, foundations and
harities were not involvement in the study design, data ac-
uisition, data analysis, manuscript preparation or manuscript
evision. 
eferences 
1] Di Costanzo S , Balasubramanian A , Pond HL , Rozkalne A , Pantale-
oni C , Saredi S , et al. POMK mutations disrupt muscle development
leading to a spectrum of neuromuscular presentations. Hum Mol Genet
2014;23(21):5781–92 . Please cite this article as: S. Strang-Karlsson et al., A n
gene causing limb-girdle muscular dystrophy-dystroglycanop
https://doi.org/10.1016/j.nmd.2018.04.012 2] von Renesse A , Petkova MV , Lützkendorf S , Heinemeyer J , Gill E , Hüb-
ner C , et al. POMK mutation in a family with congenital muscular dystro-
phy with merosin deficiency, hypomyelination, mild hearing deficit and
intellectual disability. J Med Genet 2014;51:275–82 . 
3] Ardicli D , Gocmen R , Talim B , Sprute R , Haliloglu G , Cirak S ,
et al. Congenital mirror movements in a patient with alpha-dystro-
glycanopathy due to a novel POMK mutation. Neuromusc Disord
2017;27(3):239–42 . 
4] Jae LT , Raaben M , Riemersma M , van Beusekom E , Blomen VA ,
Velds A , et al. Deciphering the glycosylome of dystroglycanopathies us-
ing haploid screens for lassa virus entry. Science 2013;340(6131):479–83 .
5] Eek MN , Kroksmark AK , Beckung E . Isometric muscle torque in chil-
dren 5 to 15 years of age: normative data. Arch Phys Med Rehabil
2006;87(8):1091–9 . 
6] Peric´ S , Glumac JN , Töpf A , Savic´-Pavic´evic´ D , Phillips L , John-
son K , et al. A novel recessive TTN founder variant is a common
cause of distal myopathy in the Serbian population. Eur J Hum Genet
2017;25(5):572–81 . 
7] Johnson K , Töpf A , Bertoli M , Phillips L , Claeys KG , Stojanovic VR ,
et al. Identification of GAA variants through whole exome sequencing
targeted to a cohort of 606 patients with unexplained limb-girdle muscle
weakness. Orphanet J Rare Dis 2017;12(1):173 . 
8] Kircher M , Witten DM , Jain P , O’Roak BJ , Cooper GM , Shendure J .
A general framework for estimating the relative pathogenicity of human
genetic variants. Nat Genet 2014;46(3):310–15 . ovel compound heterozygous mutation in the P OMK 
athy in a sib pair, Neuromuscular Disorders (2018), 
